TransCode Therapeutics Inc (RNAZ)
1.39
-0.05
(-3.47%)
USD |
NASDAQ |
May 23, 16:00
1.39
0.00 (0.00%)
After-Hours: 04:05
TransCode Therapeutics Price to Book Value: 2.008 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 2.008 |
| May 22, 2024 | 2.080 |
| May 21, 2024 | 1.806 |
| May 20, 2024 | 1.719 |
| May 17, 2024 | 1.661 |
| May 16, 2024 | 1.278 |
| May 15, 2024 | 1.165 |
| May 14, 2024 | 1.055 |
| May 13, 2024 | 0.8901 |
| May 10, 2024 | 2.037 |
| May 09, 2024 | 1.772 |
| May 08, 2024 | 1.359 |
| May 07, 2024 | 1.546 |
| May 06, 2024 | 1.086 |
| May 03, 2024 | 1.093 |
| May 02, 2024 | 0.942 |
| May 01, 2024 | 0.8391 |
| April 30, 2024 | 0.8089 |
| April 29, 2024 | 0.7821 |
| April 26, 2024 | 0.7327 |
| April 25, 2024 | 0.6995 |
| April 24, 2024 | 0.5861 |
| April 23, 2024 | 0.6128 |
| April 22, 2024 | 0.6116 |
| April 19, 2024 | 0.6145 |
| Date | Value |
|---|---|
| April 18, 2024 | 0.636 |
| April 17, 2024 | 0.6354 |
| April 16, 2024 | 0.6398 |
| April 15, 2024 | 0.6795 |
| April 12, 2024 | 0.7872 |
| April 11, 2024 | 0.8099 |
| April 10, 2024 | 0.8115 |
| April 09, 2024 | 0.8111 |
| April 08, 2024 | 0.8299 |
| April 05, 2024 | 0.8109 |
| April 04, 2024 | 0.8614 |
| April 03, 2024 | 0.8235 |
| April 02, 2024 | 0.8642 |
| April 01, 2024 | 0.8767 |
| March 28, 2024 | 2.418 |
| March 27, 2024 | 2.403 |
| March 26, 2024 | 2.336 |
| March 25, 2024 | 2.400 |
| March 22, 2024 | 2.358 |
| March 21, 2024 | 2.414 |
| March 20, 2024 | 2.478 |
| March 19, 2024 | 0.4442 |
| March 18, 2024 | 0.4355 |
| March 15, 2024 | 0.4449 |
| March 14, 2024 | 0.4442 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3117
Minimum
Jan 19 2024
3.639
Maximum
Jan 30 2023
1.446
Average
1.446
Median
Price to Book Value Benchmarks
| Citius Pharmaceuticals Inc | 1.558 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.34 |
| iBio Inc | 0.7683 |
| Theriva Biologics Inc | 0.1822 |
Price to Book Value Related Metrics
| Price | 1.39 |
| Earnings Yield | -14.82K% |
| Market Cap | 9.205M |